durvalumab,paclitaxel,carboplatin,cisplatin,gemcitabine,pemetrexed
astrazeneca
['nsclc', 'lung', 'aegean', 'sclc']
given the recent presenation at the #aacr23 of #aegean study it is even more crucial to have a go at our, , dr le pechoux,episode lung cancer considered on the treatment shifting in stage iii in nsclc, the adjuvant vs neo dilemma (in french) 
Medical Oncologist, department of oncology at the University hospital of Geneva (HUG). All opinions expressed here are my own